Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Post Menopausal Osteoporosis. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Observational, Cross-sectional, Multicenter Study to Evaluate Adherence to Different Treatment Regimens With Oral Bisphosphonates and Calcium and Vitamin D Supplements in Postmenopausal Osteoporosis.
Overview
This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usual treatments for postmenopausal osteoporosis. The study will consist of a single visit that will coincide with one of the patient's usual follow-up visits according to standard clinical practice. During this visit, information will be collected from the patient's medical history and an interview will be conducted using 3 questionnaires to assess how and how often the patient takes the treatment, possible forgetfulness, and whether or not the patient is satisfied with their current treatment.
Primary outcome measures
- Intergroup adherence [Time frame: Day 1]
Secondary outcome measures (6)
- Persistence intergroup [Time frame: Day 1]
- Adherence intragroup [Time frame: Day 1]
- Persistence intragroup [Time frame: Day 1]
- Factors of non-adherence [Time frame: Day 1]
- Factors of non-persistence [Time frame: Day 1]
- Treatment satisfaction [Time frame: Day 1]
Eligibility criteria
Inclusion criteria
- \- Women diagnosed with postmenopausal OP.
- \- Women who had been prescribed oral treatment with a BP administered monthly or weekly together with a Ca/D supplement (sachets or chewable tablets) administered daily, at least 6 months prior to inclusion in the study.
- \- Women who had given their written informed consent before participating in the study.
Exclusion criteria
None
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Spain · 21 centers
- Clinica Gaias Santiago — Santiago de Compostela
- CP Dr Caracuel — Córdoba
- Hospital Reina Sofia — Córdoba
- Hospital Virgen del Rocio — Seville
- CP Dr Agramonte — Palma de Mallorca
- CP Dr Balta — Palma de Mallorca
- CHU Insular - H Materno-Infantil — Las Palmas de Gran Canaria
- CHU Insular - H Materno-Infantil — Las Palmas de Gran Canaria
- … and 13 more centers
Identifiers
NCT: NCT07105163 · OSTEOAD